Ningxia Zhongke Biotechnology Co., Ltd. (600165.SS)
CNY 2.13
(4.93%)
CNY 2.13
(4.93%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 23.15 Million | 53.14 Million | -7.76 Million | -41.05 Million | -47.79 Million | -180.3 Million |
| Net Income | -516.14 Million | -170.1 Million | -29.94 Million | 23.2 Million | -52.06 Million | 11.57 Million |
| Depreciation & Amortization | 137.84 Million | 122.83 Million | 26.7 Million | 14.57 Million | 15.36 Million | 14.19 Million |
| Deferred income taxes | -279.92 Thousand | 2.72 Million | 598.39 Thousand | -3.12 Million | -3.9 Million | -1.67 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 70.86 Million | -7.88 Million | 1.87 Million | -56.9 Million | -28.4 Million | -195.29 Million |
| Other non-cash items | 143.54 Million | 108.29 Million | -6.4 Million | -21.93 Million | 17.3 Million | -10.77 Million |
| Investing Cash Flow | -55.68 Million | -543.19 Million | -15.77 Million | -676.52 Million | -274.48 Million | 205.01 Million |
| Investments in PPE | -57.68 Million | -59.3 Million | -250.55 Million | -732.9 Million | -499.28 Million | -73.5 Million |
| Acquisitions | -2.21 Million | -498 Million | 218.07 Million | 41.62 Million | 207.64 Million | 300 Million |
| Investment purchases | - | 483.88 Million | 1.38 | 0.53 | 499.5 Million | -38.43 Million |
| Sales/Maturities of investments | - | 14.11 Million | 14.11 Million | 14.11 Million | 16.93 Million | 16.93 Million |
| Other Investing Activities | 4.21 Million | -483.88 Million | 2.59 Million | 633 Thousand | -499.28 Million | 10 Thousand |
| Financing Cash Flow | 11.69 Million | 443.39 Million | -71.74 Million | 769.21 Million | 430.78 Million | -47.24 Million |
| Debt repayment | -19.02 Million | -400 Million | -601.8 Million | -511.1 Million | -662 Million | -368.4 Million |
| Dividends payments | -23.25 Million | -53.13 Million | -55.29 Million | -46.74 Million | -44.79 Million | -20.62 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 15.92 Million | 896.52 Million | 585.34 Million | 1.32 Billion | 1.13 Billion | 341.77 Million |
| Accounts receivables | -25.43 Million | -16.69 Million | 4.57 Million | -18.68 Million | -32.2 Million | 4.54 Million |
| Accounts payables | 61.25 Million | -54.5 Million | 181.52 Million | -57.68 Million | -6.18 Million | -176.8 Million |
| Inventory | 35.32 Million | 60.58 Million | -21.38 Million | 22.59 Million | 13.88 Million | -21.35 Million |
| Other working capital | 2.32 Million | 2.72 Million | -162.84 Million | -3.12 Million | -3.9 Million | -173.93 Million |
| Cash at beginning of period | 42.11 Million | 86.24 Million | 182.22 Million | 130.71 Million | 22.12 Million | 44.77 Million |
| Cash at end of period | 21.83 Million | 42.11 Million | 86.24 Million | 182.22 Million | 130.71 Million | 22.12 Million |
| Capital Expenditure | -57.68 Million | -59.3 Million | -250.55 Million | -732.9 Million | -499.28 Million | -73.5 Million |
| Effect of forex changes on cash | 546.04 Thousand | 2.52 Million | -688.81 Thousand | -124.13 Thousand | 98.23 Thousand | -107.3 Thousand |
| Net cash flow / Change in cash | -20.28 Million | -44.13 Million | -95.97 Million | 51.5 Million | 108.59 Million | -22.64 Million |
| Free Cash Flow | -34.52 Million | -6.16 Million | -258.32 Million | -773.96 Million | -547.08 Million | -253.81 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -54.57 Million | -373.5 Million | -51.45 Million | -516.14 Million | -245.28 Million | -83.45 Million |
| Depreciation & Amortization | - | 30.89 Million | 30.89 Million | 137.84 Million | 137.84 Million | -69.1 Million |
| Deferred income taxes | - | - | - | -279.92 Thousand | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -15.94 Million | - | 70.86 Million | 12.21 Million | -45.55 Million |
| Other non-cash items | 58.92 Million | 394.43 Million | 51.12 Million | 143.54 Million | 148.89 Million | 192.9 Million |
| Investing Cash Flow | -638.43 Thousand | -1.34 Million | 1.77 Million | -55.68 Million | -40.24 Million | -1.34 Million |
| Investments in PPE | -638.43 Thousand | -1.34 Million | -726.15 Thousand | -57.68 Million | -42.45 Million | -1.34 Million |
| Acquisitions | - | - | 2.49 Million | -2.21 Million | -1.71 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 2.49 Million | 4.21 Million | 3.92 Million | - |
| Financing Cash Flow | -1.94 Million | -478.36 Thousand | -4.25 Million | 11.69 Million | -782.94 Thousand | 3.22 Million |
| Debt repayment | -1.55 Million | -2.69 Million | -60 Thousand | -19.02 Million | -15.12 Million | -30 Million |
| Dividends payments | - | -1.01 Million | -958.54 Thousand | -23.25 Million | -4.43 Million | -10.94 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -386.04 Thousand | 2.21 Million | -3.23 Million | 15.92 Million | -20.33 Million | 44.17 Million |
| Accounts receivables | - | 22.19 Million | - | -25.43 Million | -25.43 Million | -3.66 Million |
| Accounts payables | - | - | - | 61.25 Million | - | - |
| Inventory | - | -38.14 Million | - | 35.32 Million | 35.32 Million | -41.89 Million |
| Other working capital | - | - | - | 2.32 Million | 2.32 Million | - |
| Cash at beginning of period | 10.55 Million | 21.58 Million | 21.83 Million | 42.11 Million | 9.33 Million | 12.25 Million |
| Cash at end of period | 12.33 Million | 10.55 Million | 19.02 Million | 21.83 Million | 21.83 Million | 9.33 Million |
| Capital Expenditure | -638.43 Thousand | -1.34 Million | -726.15 Thousand | -57.68 Million | -42.45 Million | -1.34 Million |
| Effect of forex changes on cash | - | 629.28 Thousand | - | 546.04 Thousand | -142.37 Thousand | 405.24 Thousand |
| Net cash flow / Change in cash | 1.77 Million | -11.03 Million | -2.81 Million | -20.28 Million | 12.5 Million | -2.92 Million |
| Free Cash Flow | 3.7 Million | -11.31 Million | -1.05 Million | -34.52 Million | 11.21 Million | -6.55 Million |
IPCALAB
ORIENTCEM
IFBC
FIISO
1712
TLTFF